Lucero awarded 900 000 SEK Vinnova Innovative Startups Stage 2 grant to build on Stage 1 progress in preparation for an on-site pharmaceutical pilot project and Seed round funding.
The project’s technical milestones are focused on further de-risking Lucero’s optical tweezers through work with primary human hepatocyte cells and improving the accuracy and functionality of our AI-powered cell-tracking software. Lucero plans to move towards a semi-automated system that can be used in a pharmaceutical pilot after the completion of the project.
The Lucero team will also work to gather further market proof from potential customers to help guide technical development and prepare the company for a possible Seed round in 2023.
We’re grateful for the continued support from Vinnova. We made significant progress during Lucero’s Stage 1 project, but we still have a ways to go. This money will fund critical technical and business milestones that will put us in a great position for our next phase of development. – Christopher Jacklin, co-founder of Lucero
Innovative Startups Stage 2 is open to recipients of Vinnova’s Innovative Startups Stage 1 grant. The call funds the further development of Stage 1 results and targets early-stage startups that are still too risky to attract external capital.